Molex to Acquire Vectura Group From Philip Morris International (PMI)
September 17, 2024
Vectura Group Ltd., a subsidiary of Philip Morris International (PMI) and part of Vectura Fertin Pharma, has signed an agreement to be sold to Molex Asia Holdings Ltd. The deal includes upfront cash consideration of GBP 150 million (subject to customary adjustments) plus potential deferred payments of up to GBP 148 million, with closing subject to regulatory approvals and other customary conditions.
- Buyers
- Molex Asia Holdings Ltd., Phillips Medisize
- Targets
- Vectura Group Ltd., Vectura Fertin Pharma
- Sellers
- Philip Morris International Inc. (PMI)
- Platforms
- Phillips Medisize
- Industry
- Medical Devices
- Location
- United Kingdom
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Molex Completes Acquisition of Smiths Interconnect
October 16, 2025
IT Services
Molex has completed the acquisition of Smiths Interconnect, a subsidiary of Smiths Group plc, expanding Molex’s portfolio of high-reliability connectivity solutions. The deal adds ruggedized custom connectors, RF components, optical transceivers, and semiconductor test capabilities, strengthening Molex’s reach across aerospace and defense, medical, and AI-driven infrastructure use cases.
-
Jabil Acquires Pharmaceutics International (Pii)
February 6, 2025
Pharmaceuticals
Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.
-
Philip Morris International to Acquire Vectura Group
July 9, 2021
Healthcare Services
Philip Morris International (PMI) announced it has agreed to an all-cash, recommended offer to acquire Vectura Group plc for an enterprise value of GBP 852 million (approximately USD 1.2 billion). The deal is expected to close in the second half of 2021, subject to shareholder and regulatory approvals.
-
Philip Morris International Acquires Fertin Pharma from EQT Private Equity
July 1, 2021
Pharmaceuticals
Philip Morris International has agreed to acquire Fertin Pharma, a Denmark-headquartered specialist CDMO in oral and intra-oral delivery technologies, from EQT Private Equity for a headline enterprise value of DKK 5.1 billion. Fertin Pharma — which operates sites in Denmark, Canada and India and employs more than 860 people — will strengthen PMI's smoke-free and beyond-nicotine product capabilities; the transaction is subject to customary approvals.
-
H.I.G. Capital Acquires BioVectra Inc.
November 4, 2019
Pharmaceuticals
H.I.G. Capital, through an affiliate, completed the acquisition of BioVectra Inc., a Canadian contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredients (APIs), intermediates and biologics. The deal — a carve-out from Mallinckrodt — positions H.I.G. to support BioVectra's growth and further expand its manufacturing capabilities across Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
-
Volex PLC Acquires MC Electronics LLC
June 4, 2018
Manufacturing
Volex PLC acquired MC Electronics LLC from Nova Capital Management, completing a deal announced in April 2018 and reported in June 2018. MC Electronics, based in Hollister, California with manufacturing in Juarez, Mexico, is a contract manufacturer of custom cables, wire harnesses and electromechanical assemblies for the medical equipment industry; Volex said the acquisition expands its cable assembly capabilities and customer relationships.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.